Benefits
BPH Symptom Improvement
Plasys300 designed to improve symptoms of benign prostatic hyperplasia — urinary frequency, urgency, weak flow, nocturia, incomplete emptying.
Urinary Flow Support
Targeted at the urinary symptoms of BPH which result from prostate enlargement compressing urethra.
Prostate Health for Aging Men
BPH affects 50%+ of men by age 50, 80%+ by age 80; Plasys300 positioned for this large aging male demographic.
Standardized Botanical Formulation
Pharmactive standardization ensures consistent active compound delivery for reproducible BPH symptom relief.
Alternative or Adjunct to BPH Medications
Useful for men: avoiding prescription medications, with mild-moderate symptoms, or as adjunct to alpha-blockers/5α-reductase inhibitors.
Mechanism of action
Prostate-Specific Activity
Plasys300 designed for prostate tissue effects per Pharmactive research; mechanism includes addressing BPH symptom drivers.
Urinary Symptom Pathway Effects
Mechanism likely involves prostate tissue, bladder/urethra effects, possible inflammatory pathway modulation common in BPH science.
Standardized Active Compound Delivery
Pharmactive standardization for clinically reproducible effects.
Clinical trials
Pharmactive clinical trials of Plasys300 for BPH symptom management.
Men with BPH symptoms.
Improvements in BPH-related urinary symptoms and quality of life.